Track the Cipla Limited share price and the full insider trade history of the company, a listed issuer based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Cipla Limited has logged 35 insider filings. Market capitalisation: €1,184.6bn. The latest transaction was filed on 30 September 2025 (Sale). Among the most active insiders: Vidya Prabhakar Rote jointly with Kiran Rote. All data is free.
35
Insider Decl.
n/a
Thresholds
€143,568
28 ops.
Buy Volume
€110,623
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cipla Limited Buy (bullish), based on 37 analysts. Average price target: ₹1,512.86.
10Σ signal
Buys €143,568€110,623 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,479 of 28,855 companies
60.1
score / 100
Value
41
Quality
79
FCF yld0.7%
Earn yld3.3%
EV/EBITDA18.7x
ROE12%
Gross mgn62%
Net mgn14%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
51,169 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:d004047ef784c2bb14c2e26db7456af9b5a0ecab
25 of 35 declarations
About Cipla Limited
Cipla Limited is an Indian pharmaceutical company that specializes in the manufacturing of generic drugs and healthcare products. It is listed on the Bombay Stock Exchange under the symbol XBOM.